NUVB (STOCKS)
Nuvation Bio Inc.
$5.110000
+0.190000 (+3.86%)
Prev close: $4.920000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- David T. Hung
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,793.15M
- Employees
- 291
- P/E (TTM)
- -12.01
- P/B (TTM)
- 5.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $143.05M |
| Benefits Costs and Expenses | $289.04M |
| Costs And Expenses | $289.04M |
| Nonoperating Income/Loss | $4.19M |
| Operating Expenses | $295.32M |
| Selling, General, and Administrative Expenses | $154.48M |
| Depreciation and Amortization | $1.97M |
| Research and Development | $125.55M |
| Other Operating Expenses | $11.23M |
| Operating Income/Loss | -$150.18M |
| Income/Loss From Continuing Operations After Tax | -$145.99M |
| Income/Loss From Continuing Operations Before Tax | -$145.99M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$145.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$145.99M |
| Net Income/Loss Available To Common Stockholders, Basic | -$145.99M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.42 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 1,031,415 |
| Diluted Average Shares | 1,061,604 |
| Assets | $610.24M |
| Current Assets | $591.53M |
| Inventory | $15.84M |
| Other Current Assets | $575.69M |
| Noncurrent Assets | $18.71M |
| Fixed Assets | $535.00K |
| Other Non-current Assets | $18.18M |
| Liabilities | $290.68M |
| Current Liabilities | $79.52M |
| Accounts Payable | $22.44M |
| Other Current Liabilities | $57.09M |
| Noncurrent Liabilities | $211.16M |
| Long-term Debt | $47.33M |
| Other Non-current Liabilities | $163.83M |
| Equity | $319.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $319.56M |
| Liabilities And Equity | $610.24M |
| Net Cash Flow From Operating Activities | -$125.73M |
| Net Cash Flow From Operating Activities, Continuing | -$125.73M |
| Net Cash Flow From Investing Activities | $1.70M |
| Net Cash Flow From Investing Activities, Continuing | $1.70M |
| Net Cash Flow From Financing Activities | $202.03M |
| Net Cash Flow From Financing Activities, Continuing | $202.03M |
| Exchange Gains/Losses | -$588.00K |
| Net Cash Flow | $77.41M |
| Net Cash Flow, Continuing | $78.00M |
| Comprehensive Income/Loss | -$148.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$148.22M |
| Other Comprehensive Income/Loss | $168.54M |